Label: WALGREENS LIDOCAINE BACK- lidocaine patch

  • Category: HUMAN OTC DRUG LABEL
  • DEA Schedule: None

Drug Label Information

Updated November 14, 2024

If you are a consumer or patient please visit this version.

View All Sections
  • Drug Facts

  • Active ingredient

    Lidocaine 4%

    Purpose

    Topical Analgesic

  • Use

    For temporary relief of pain

  • Warnings

    For external use only

    Do not use

    • More than one patch on your body at a time
    • On cut, irritated or swollen skin
    • On puncture wounds
    • For more than one week without consulting a doctor
    • If you are allergic to any active or inactive ingredients 
    • If pouch is damaged or opened

    When using this product

    • Use only as directed
    • Read and follow all directions and warnings
    • Do not allow contact with the eyes
    • Do not use at the same time as other topical anesthetics
    • Do not bandage tightly or apply local heat (such as heating pads) to the area of use
    • Do not microwave
    • Dispose of used patch in manner that always keeps product away from children and pets. Used patches still contain the drug product that can produce serious adverse effects if a child or pet chews or ingests this patch.

    Stop use and ask a doctor if

    • condition worsen 
    • Redness is present
    • Irritation develops
    • Symptoms persist for more than 7 days or clear up and occur again within a few days
    • You experience signs of skin injury, such as pain, swelling, or blistering where the product was applied

    If pregnant or breast feeding,

    ask a health professional before use.

    Keep out of reach of children.

    If swallowed, get medical help or contact a poison Control Center right away.

  • Directions

    Adults and children 12 years if age and over:

    • Clean and dry affected area
    • Carefully remove backing from patch
    • Apply sticky side of patch to affected area
    • Use one patch for up to 8 hours
    • Discard patch after single use
    • Apply 1 patch at a time to affected area, not more than 3 to 4 times daily

    Children under 12 years of age:consult a physician.

  • Other information

    • Store in a clean, dry place outside of direct sunlight
    • Protect from excessive moisture
  • Inactive ingredients

    A-tocopherol Acetate, CMC-2Na, Dihydroxyaluminum Aminoacetate, Fumed Silica, Glycerol, Laurocapram, PEG-40 Hydrogenated Castor Oil, Phenoxyethanol, Polyacrylic Acid, Propylene Glycol, Sodium Polyacrylate, Tartaric Acid, Titanium Dioxide, Urea, Vanillyl Butyl Ether, Water, 3-2-(Ethylhexyl)oxyl-1, 2-Propanediol.

  • Package Labelling:

    label.jpg

  • INGREDIENTS AND APPEARANCE
    WALGREENS LIDOCAINE BACK 
    lidocaine patch
    Product Information
    Product TypeHUMAN OTC DRUGItem Code (Source)NDC:0363-2178
    Route of AdministrationTOPICAL
    Active Ingredient/Active Moiety
    Ingredient NameBasis of StrengthStrength
    LIDOCAINE (UNII: 98PI200987) (LIDOCAINE - UNII:98PI200987) LIDOCAINE40 mg  in 1 g
    Inactive Ingredients
    Ingredient NameStrength
    .ALPHA.-TOCOPHEROL ACETATE (UNII: 9E8X80D2L0)  
    DIHYDROXYALUMINUM AMINOACETATE (UNII: DO250MG0W6)  
    GLYCERIN (UNII: PDC6A3C0OX)  
    LAUROCAPRAM (UNII: 1F3X9DRV9X)  
    PEG-40 HYDROGENATED CASTOR OIL (UNII: 7YC686GQ8F)  
    PHENOXYETHANOL (UNII: HIE492ZZ3T)  
    PROPYLENE GLYCOL (UNII: 6DC9Q167V3)  
    TARTARIC ACID (UNII: W4888I119H)  
    TITANIUM DIOXIDE (UNII: 15FIX9V2JP)  
    UREA (UNII: 8W8T17847W)  
    VANILLYL BUTYL ETHER (UNII: S2ULN37C9R)  
    WATER (UNII: 059QF0KO0R)  
    Packaging
    #Item CodePackage DescriptionMarketing Start DateMarketing End Date
    1NDC:0363-2178-016 in 1 BOX10/20/2024
    11 in 1 BAG
    17 g in 1 PATCH; Type 0: Not a Combination Product
    Marketing Information
    Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
    OTC Monograph DrugM01710/20/2024
    Labeler - Walgreen Co. (008965063)
View All Sections

Find additional resources

(also available in the left menu)

Safety

Report Adverse Events, FDA Safety Recalls, Presence in Breast Milk

Related Resources

Medline Plus, Clinical Trials, PubMed, Biochemical Data Summary

More Info on this Drug

View Labeling Archives, RxNorm, Get Label RSS Feed, View NDC Code(s)NEW!